Examining the Presence of Sarcopenia in Women with Rheumatoid Arthritis: Case-Control Study.
Rheumatoid arthritis
muscle
physical performance
quality of life
sarcopenia
Journal
Romanian journal of internal medicine = Revue roumaine de medecine interne
ISSN: 2501-062X
Titre abrégé: Rom J Intern Med
Pays: Germany
ID NLM: 9304507
Informations de publication
Date de publication:
28 Dec 2023
28 Dec 2023
Historique:
received:
03
10
2023
medline:
28
12
2023
pubmed:
28
12
2023
entrez:
28
12
2023
Statut:
aheadofprint
Résumé
The aim of this study was to compare the frequency of sarcopenia, functional status, fear-avoidance behaviors, biopsychosocial status and quality of life in RA women with healthy controls. 25 RA women and 25 healthy women were included in the study. Definition of sarcopenia was assessed using parameters recommended by the European Working Group on Sarcopenia (EWGSOP): Bioimpedance analysis for muscle mass (body fat ratio, skeletal muscle mass, skeletal muscle mass index); grip and knee extension strength for muscle strength and 4-m course gait speed test for physical performance was applied. Functional status was evaluated with the Health Assessment Questionnaire (HAQ), fear-avoidance behaviors with the Tampa Kinesiophobia Scale (TKS), biopsychosocial status with the Biopsychosocial Questionnaire (BETY-BQ), and quality of life with Short Form-36 (SF-36). While none of the healthy women had sarcopenia, severe sarcopenia was detected in 7 (28%) of the women with RA. When RA and healthy groups were compared; skeletal muscle mass (p: 0,004); skeletal muscle mass index (p: 0,011); grip strength-right (p:0.001) and left (p:0.001); knee extension strength-right (p:0.001) and left (p:0.001), 4-m course gait speed test (p:0.001), HAQ (p:0.001), TKS (p:0.001), BETY-BQ (p:0.001), SF-36 physical (p:0.001) ve mental component (p:0.001) results were significant in favor of the healthy group while there was no difference in body fat ratio (p>0.05). In women with RA, the frequency of sarcopenia is higher, and functional status, fear-avoidance behaviors, biopsychosocial status and quality of life are worse than healthy.
Identifiants
pubmed: 38153879
pii: rjim-2023-0036
doi: 10.2478/rjim-2023-0036
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 Begüm Akar et al., published by Sciendo.
Références
ALETAHA D, NEOGİ T, SİLMAN AJ, FUNOVİTS J, FELSON DT, BİNGHAM III CO, ET AL. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9): 2569-2581.
GRAVALLESE EM, FİRESTEİN GS. Rheumatoid Arthritis - Common Origins, Divergent Mechanisms . N Engl J Med. 2023;388(6):529-542.
SCHERER HU, HAUPL T, BURMESTER GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020; 110: 102400.
YANG J, LI Q. Rheumatoid Arthritis. N Engl J Med. 2023;388(20):1919.
ALIVERNINI S, FIRESTEIN GS, McINNES IB. The pathogenesis of rheumatoid arthritis . Immunity. 2022;55(12):2255-2270.
YUAN S, LARSSON SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism. 2023;144:155533.
VOGELE D, OTTO S, SOLLMANN N, HAGGENMÜLLER B, WOLF D, BEER M, SCHMİDT SA. Sarcopenia - Definition, Radiological Diagnosis, Clinical Significance. Rofo. 2023;195(5):393-405.
CRUZ-JENTOFT AJ, BAEYENS JP, BAUER JM, BOİRİE Y, CEDERHOLM T, LANDİ F, ET AL. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39: 412-423.
WU D, LUO Y, LI T, ZHAO X, LV T, FANG G, et al. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Front Immunol. 2022 Dec 22;13:1051082.
BANO G, TREVİSAN C, CARRARO S, ET AL. Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas. 2017; 96: 10-15.
RALL LC, ROUBENOFF R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions Rheumatology. 2004; 43(10): 1219-23.
NGEULEU A, ALLALİ F, MEDRARE L, MADHİ A, RKAİN H, HAJJAJ-HASSOUNİ N. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatol Int. 2017; 37(6): 1015-1020.
BAHAT G, TUFAN A, TUFAN F, KİLİC C, AKPİNAR TS, KOSE M, ET AL. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016; 35(6): 1557-63.
ROBERTS HC, DENİSON HJ, MARTİN HJ, PATEL HP, SYDDALL H, COOPER C, SAYER AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011; 40(4): 423-9
TRUDELLE-JACKSON E, JACKSON AW, FRANKOWSKİ CM, LONG KM, MESKE NB. Interdevice Reliability and Validity Assessment Of The Nicholas Hand-Held Dynamometer. J Orthop Sports Phys Ther. 1994; 20: 302-6.
FRİES JF, SPİTZ PW, YOUNG DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9(5):789-93.
VLAEYEN JWS, KOLE-SNİJDERS AMJ, ROTTEVEEL AM, ET AL. The role of fear of movement/(re)injury in pain disability. J Occup Rehab. 1995; 5(4): 235-252.
KUMBAROĞLU FB, KARAKAYA KARABULUT J, APRAŞ BİLGEN Ş, ÜNAL E. Determination of the validity, reliability, and sensitivity of the BETY- Biopsychosocial Questionnaire in patients with a diagnosis of rheumatoid arthritis. JETR. 2021; 8(1): 90-98.
WARE JE JR, SHERBOURNE CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30 (6): 473-83.
TEKGOZ E, COLAK S, OZALP ATES FS, SONAEREN I, YİLMAZ S, CİNAR M. Sarcopenia in rheumatoid arthritis: Is it a common manifestation? Int J Rheum Dis. 2020; 23(12): 1685–1691.
AMİNOV K. Sarcopenia and osteoporosis in patients with rheumatoid arthritis . Ann Rheum Dis. 2017; 76: 1351
REİNA D, GÓMEZ-VAQUERO C, DÍAZ-TORNÉ C, SOLÉ JMN. Assessment of nutritional status by dual X-Ray absorptiometry in women with rheumatoid arthritis: A case-control study. Medicine (Baltimore). 2019; 98(6): e14361.
DAO HH, DO QT, SAKAMOTO J. Abnormal body composition phenotypes in Vietnamese women with early rheumatoid arthritis . Rheumatology. 2011; 50(7): 1250-8.
DOĞAN SC, HİZMETLİ S, HAYTA E, KAPTANOĞLU E, ERSELCAN T, GÜLER E. Sarcopenia in women with rheumathoid arthritis. Eur J Rheumatol. 2015; 2(2): 57–61.
ALKAN-MELİKOĞLU M. Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. Arch Rheumatol. 2017; 32(1): 53-59.
TADA M, YAMADA Y, MANDAİ K, HİDAKA N. Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis-results from the CHIKARA study. Int J Rheum Dis. 2018; 21(11): 1962-1969.
KEEFE FJ, SMİTH SJ, BUFFİNGTON AL, ET AL. Recent advances and future directions in the biopsychosocial assessment and treatment of arthritis . J Consult Clin Psychol. 2002; 70(3): 640-655.
UHLİG T, LOGE JH, KRİSTİANSEN IS, ET AL. Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. J Rheumatol. 2007; 34(6): 1241-1247.
LEE MK, JEONG HH, KİM MJ, RYU H, BAEK J, LEE B. Nutrients against Glucocorticoid-Induced Muscle Atrophy. Foods. 2022;11(5):687.
HEIN TR, PETERSON L, BARTIKOSKI BJ, PORTES J, ESPIRITO SANTO RC, XAVIER RM. The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis. Arthritis Res Ther. 2022;24(1):171.
YAMADA Y, TADA M, MANDAI K. HIDAKA N, INUI K, NAKAMURA H. Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study. Clin Rheumatol. 2020;39:1757–1764.
MOSCHOU D, KRIKELIS M, GEORGAKOPOULOS C, MOLE E, CHRONOPOULOS E, TOURNIS S, et al. Sarcopenia in Rheumatoid arthritis. A narrative review. J Frailty Sarcopenia Falls. 2023;8(1):44-52.